Compulsory licensing of essential medicines - the reality

The recent battle over licensing, compulsory or otherwise, of HIV/AIDS drugs between Brazil, the United States and pharmaeutical companies seems to be coming to a head. The US and companies are not happy, concerned that a "large" economy such as Brazil will gain unjustified benefit from patents; NGOs are not happy because they see Brazil as failing to act to impose compulsory licences as the negotiations are not leading anywhere.

A test of the apparent balances in TRIPS and subsequent instruments. IP doesn't seem to be working right, competition law might not be being allowed to try to work and human rights to life, health and dignity seem to be losing out to other rights. Some not quite right... Excellent overview provided by CPTECH.